I read today in the NY Times an article about the extension of a patent on the best-selling Alzheimer’s drug Aricept. In order to keep the lucrative patent protection, the drug’s maker, Pfizer, just radically upped the dosage in the tablets. After study of the effects of the new dosage, the researcher recommended against its approval. Serious side effects, including nausea and vomiting (especially problematic for the elderly, frail and mentally impaired) and increased death rates (now, that is a pretty serious side effect),... Read more